bedaquiline
Selected indexed studies
- Bedaquiline: what might the future hold? (Lancet Microbe, 2024) [PMID:39074472]
- Bedaquiline-Pretomanid-Linezolid Regimens for Drug-Resistant Tuberculosis. (N Engl J Med, 2022) [PMID:36053506]
- Bedaquiline in Drug-Resistant Tuberculosis: A Mini-Review. (Curr Mol Pharmacol, 2023) [PMID:36919348]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Bedaquiline: what might the future hold? (2024) pubmed
- Bedaquiline-Pretomanid-Linezolid Regimens for Drug-Resistant Tuberculosis. (2022) pubmed
- Bedaquiline in Drug-Resistant Tuberculosis: A Mini-Review. (2023) pubmed
- Bedaquiline: Current status and future perspectives. (2021) pubmed
- Bedaquiline for treatment of non-tuberculous mycobacteria (NTM): a systematic review and meta-analysis. (2024) pubmed
- Bedaquiline Resistance: A Looming Global Threat in Tuberculosis Management. (2025) pubmed
- Bedaquiline: An Insight Into its Clinical Use in Multidrug-Resistant Pulmonary Tuberculosis. (2024) pubmed
- Bedaquiline and delamanid for drug-resistant tuberculosis: a clinician's perspective. (2020) pubmed
- Bedaquiline Monotherapy for Multibacillary Leprosy. (2024) pubmed
- A structural insight of bedaquiline for the cardiotoxicity and hepatotoxicity. (2019) pubmed